Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Markus Albertsmeier

LMU University Hospital

Germany

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Surgery

50%

Obstetrics And Gynecology

20%

Oncology

50%

Gastrointestinal Surgery

40%

Pancreatic Cancer

30%

Neoadjuvant Therapy

30%

Cancer Biology

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles17

ASO Author Reflections: Modelling Morbidity in Retroperitoneal Sarcoma—Multimodal Therapy is Safe While Surgery Sets the Tone

Article Link

Year:

2025

Doxorubicin Plus Dacarbazine Versus Doxorubicin Plus Ifosfamide in Combination With Regional Hyperthermia in Patients With Advanced Leiomyosarcoma: A Propensity Score‐Matched Analysis

Article Link

Year:

2025

Refusal of Adjuvant Therapies and Its Impact on Local Control and Survival in Patients with Bone and Soft Tissue Sarcomas of the Extremities and Trunk

Article Link

Year:

2024

Differentiation of benign and metastatic lymph nodes in soft tissue sarcoma

Article Link

Year:

2024

Effect of Surgery on Postoperative Levels of the Gut Homeostasis-Regulating Enzyme Intestinal Alkaline Phosphatase

Article Link

Year:

2024

Intraoperative Wound Irrigation for the Prevention of Surgical Site Infection After Laparotomy

Article Link

Year:

2024

Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ductal adenocarcinoma: The HEAT randomised clinical trial

Article Link

Year:

2023

Staphylococcus aureus surgical site infection rates in 5 European countries

Article Link

Year:

2023

Histology-Based Prediction of Therapy Response to Neoadjuvant Chemotherapy for Esophageal and Esophagogastric Junction Adenocarcinomas Using Deep Learning

Article Link

Year:

2023

TIM-3 Qualifies as a Potential Immunotherapeutic Target in Specific Subsets of Patients with High-Risk Soft Tissue Sarcomas (HR-STS)

Article Link

Year:

2023

Author response to: Comment on: Effects of the short stitch technique for midline abdominal closure on incisional hernia (ESTOIH): randomized clinical trial

Article Link

Year:

2023

VISTA in Soft Tissue Sarcomas: A Perspective for Immunotherapy?

Article Link

Year:

2022

A novel immune-related gene signature predicting survival in sarcoma patients

Article Link

Year:

2022

Effects of the short-stitch technique for midline abdominal closure: short-term results from the randomised-controlled ESTOIH trial

Article Link

Year:

2022

A survey among physicians in surgery and anesthesiology departments after the first surge of SARS-CoV-2 infections in Germany: Preparing for further challenges ahead

Article Link

Year:

2022

Correction: Morbidity and Outcomes After Distal Pancreatectomy for Primary Retroperitoneal Sarcoma: An Analysis by the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group (Annals of Surgical Oncology, (2021), 28, 11, (6882-6889), 10.1245/s10434-021-09739-9)

Article Link

Year:

2022

Management of Locally Recurrent Retroperitoneal Sarcoma in the Adult: An Updated Consensus Approach from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group

Article Link

Year:

2022

Collaborators9

Vittorio Lorenzo Quagliuolo

Chief

IRCCS Humanitas Research Hospital

ITALY

Annika Yanina Claßen

GERMANY

Hans Roland Dürr

GERMANY

Markus W. Löffler

University Hospital Tübingen

GERMANY

Fabian Hörst

University Hospital Essen

GERMANY

Haochen Yu

GERMANY

Felix Carlo Koehler

Exzellenzcluster CECAD in der Universität zu Köln

GERMANY

Rolf Issels

Professor

Klinikum der Universität München

GERMANY

Sibylle Mellinghoff

University Hospital Bonn

GERMANY

How do I reach out?

Meet Kite AI